Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02272023 · ClinicalTrials.gov registry record · NA

Randomized Trial of Intensive Motivational Interviewing (IMI) to Improve Drinking Outcomes Among Women

A NA study of Alcohol Use Disorders, sponsored by Public Health Institute, California.

Completed
Registry status
NA
Development phase
215
Enrollment target
1
Study location

NCT02272023 is a NA study of Alcohol Use Disorders that has completed, run by Public Health Institute, California. The registered enrollment target is 215 participants, above the 96-participant average among 8 other Alcohol Use Disorders trials with a reported enrollment target (124% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02272023, a NA study of Alcohol Use Disorders, has completed, sponsored by Public Health Institute, California.

COMPLETED
Registry status
NA
Development phase
215 participants
Enrollment target
1
Study location

Study Summary

A Phase II Randomized Clinical Trial (RCT) is proposed to compare a 9-session model of intensive motivational interviewing (IMI) to standard motivational interviewing techniques (SMI) among alcohol dependent women. Preliminary work studying 87 women randomly assigned to IMI or a standard single session of motivational interviewing showed significantly better drinking outcomes for women in the IMI condition at 4- and 6-month follow-up. Interestingly, mean trajectories for women assigned to IMI showed continuing declines in drinking problems during and after treatment. Differences between study conditions grew larger between 4-month (p\<.05) and 6-month (p\<.01) follow-up and the effect size at 6 months was medium to large (Cohen's d=0.63) The study will use mixed model quantitative and qualitative methods to respond to the PA's call for studies assessing mechanisms of change. Unlike many previous studies of SMI, we will employ limited exclusion criteria and will enroll participants who present with co-existing drug and psychiatric disorders. Procedures for the proposed study draw from our current successful RCT assessing IMI for methamphetamine (MA) dependence. Successful aspects of the current study include achievement of recruitment goals, strong adherence to the treatment and research protocols, and excellent rates for follow-up interviews (\>90%). The proposed study will take place at the same outpatient treatment program as the current study, New Leaf Treatment Center in Lafayette, California. Participants will include 220 alcohol dependent women who will be randomly assigned to IMI or SMI. Those in SMI will also receive an attention component (nutrition education) to achieve time equivalence between the two study conditions. Participants in both groups will receive standard weekly group treatment offered at the program. In addition, referrals to Alcoholics Anonymous will be provided to all participants. The primary outcomes will be measures of drinking, heavy

Conditions Studied

Interventions

  • BEHAVIORAL Intensive Motivational Interviewing
  • BEHAVIORAL Single session of Motivational Interviewing

Study Locations (1)

California

  • New Leaf Treatment Center - Lafayette

Trial Details

FieldValue
Enrollment Target 215 participants
Start Date 2015-02
Est. Completion 2019-03-07
Phase NA

What the Registry Record Tells You About NCT02272023

The ClinicalTrials.gov registry entry for NCT02272023 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 96-participant average among 8 other Alcohol Use Disorders trials with a reported enrollment target (124% higher). The listed sponsor is Public Health Institute, California, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Intensive Motivational Interviewing is the first listed.

NCT02272023 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02272023 about?

NCT02272023 is a clinical study titled "Randomized Trial of Intensive Motivational Interviewing (IMI) to Improve Drinking Outcomes Among Women". A Phase II Randomized Clinical Trial (RCT) is proposed to compare a 9-session model of intensive motivational interviewing (IMI) to standard motivational interviewing techniques (SMI) among alcohol dependent women. Preliminary work studying 87 women randomly assigned to IMI or a standard single sess...

What is the current status of trial NCT02272023?

This trial is currently completed. It is a NA study. The enrollment target is 215 participants. The study started on 2015-02. Estimated completion is 2019-03-07.

What conditions does trial NCT02272023 study?

This clinical trial studies the following conditions: Alcohol Use Disorders.

What interventions are being tested in trial NCT02272023?

The interventions under investigation include: Intensive Motivational Interviewing (BEHAVIORAL), Single session of Motivational Interviewing (BEHAVIORAL).

Who is sponsoring clinical trial NCT02272023?

This trial is sponsored by Public Health Institute, California, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02272023 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.